We passionately improve health

Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies.

Homepage - Our Vision

Our Company

Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and a total of around 47,500 employees. 

Read moreon Boehringer Ingelheim
Homepage Banner

Human Pharma

What We Focus On

Human Pharma​ covers the following disease areas; Respiratory, Oncology, Diabetes, and Cardiovascular; and is aimed at providing effective primary and specialist care across indications, in order to improve the quality of life of patients in the Middle East and North Africa. 

Read more on What We Focus On
Animal Health
Animal Health

Animal Health

Dedicated to Protecting and Improving the Health of Animals

Human Pharma​ covers the following disease areas; Respiratory, Oncology, Diabetes, and Cardiovascular; and is aimed at providing effective primary and specialist care across indications, in order to improve the quality of life of patients in the Middle East and North Africa. 

Read more on Dedicated to Protecting and Improving the Health of Animals
Employees

Careers

Working at Boehringer Ingelheim – Being part of a global family

As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.

Read moreon

Working at Boehringer Ingelheim – Being part of a global family

Explore Our Content

Latest Press Releases

PRESS RELEASE 08 Nov 2018 at 11:59

Ahead of World Diabetes Day Findings released identify severe knowledge gaps with 67% of patients don’t believe that Type 2 Diabetes is associated with increased cardiovascular diseases risk
Read more on Ahead of World Diabetes Day Findings released identify severe knowledge gaps with 67% of patients don’t believe that Type 2 Diabetes is associated with increased cardiovascular diseases risk

PRESS RELEASE 06 Nov 2018 at 16:48

Patient Survey released identify severe knowledge gaps with 74% of patients don’t believe that type 2 diabetes is associated with increased cardiovascular diseases risks
Read more on Patient Survey released identify severe knowledge gaps with 74% of patients don’t believe that type 2 diabetes is associated with increased cardiovascular diseases risks

PRESS RELEASE 04 Dec 2018 at 18:58

Boehringer Ingelheim launches ‘LastMile’ initiative to address major barriers in animal healthcare sector in Sub-Saharan Africa
Read more on Boehringer Ingelheim launches ‘LastMile’ initiative to address major barriers in animal healthcare sector in Sub-Saharan Africa